{"id":"W2613203965","doi":"10.1016/j.cjca.2017.04.012","title":"A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; University of British Columbia; McMaster University; LMC Diabetes & Endocrinology (Canada); McGill University Health Centre; North York General Hospital; Université Laval; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Empagliflozin; Intensive care medicine; Liraglutide; Type 2 diabetes; Diabetes mellitus; Adverse effect; Residual risk; Risk analysis (engineering); Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004813885,0.002060776,0.002562992,0.004072713,0.001147034,0.002729442,0.002859225,0.008070755,0.0398472],"category_scores_gemma":[0.01787677,0.001190991,0.001759361,0.001601134,0.001595594,0.003411576,0.001610174,0.01271149,0.03548449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001151961,"about_ca_system_score_gemma":0.005306484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004294149,"about_ca_topic_score_gemma":0.01241006,"domain_scores_codex":[0.996855,0.00112323,0.0006961004,0.0001649375,0.001022232,0.0001384318],"domain_scores_gemma":[0.989094,0.005362863,0.0008953089,0.0003291466,0.003091857,0.001226883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001406884,0.0004594831,0.000415849,0.000864535,0.00002852396,0.001252789,0.0001598915,0.0004280904,0.0008331416,0.005373027,0.7574807,0.2325633],"study_design_scores_gemma":[0.0002534159,0.000383376,0.001659569,0.003496174,0.00003671657,0.003608255,0.0002361125,0.0006549146,0.0002933439,0.01406436,0.9752321,0.00008171246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.002818062,0.173754,0.1301415,0.4464121,0.02965565,0.002796883,0.006484834,0.005971602,0.2019654],"genre_scores_gemma":[0.01234426,0.1827934,0.3615273,0.2608162,0.02802045,0.005697513,0.005873564,0.00153229,0.1413949],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.0398472,"threshold_uncertainty_score":0.1333022,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06126338434389308,"score_gpt":0.2987993638879605,"score_spread":0.2375359795440674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}